Tag

Immunicum

Board

Immunicum announces updated executive management team

March 16, 2021

Immunicum has announced the establishment …

Jeroen Rovers

Immunicum appoints new Chief Medical Officer

March 7, 2021

Immunicum has announced that Jeroen …

Sven Rohmann Immunicum

Immunicum receives orphan drug designation

February 22, 2021

The European Medicines Agency Committee …

In a new job

Immunicum recruits new Interim CFO

February 1, 2021

Immunicum has announced that effective …

Sven Rohmann Immunicum

Immunicum receives Orphan Drug Designation

January 26, 2021

Immunicum has received Orphan Drug …

Sven Rohmann Immunicum

Immunicum completes patient recruitment for Phase Ib trial

December 21, 2020

Immunicum has announced the completion …

Sven Rohmann Immunicum

Immunicum receives Fast Track Designation

December 8, 2020

Immunicum has received Fast Track …

Sven Rohmann Immunicum

Immunicum acquires all shares in DCprime

November 19, 2020

Immunicum has entered into an …

Immunicum announces next safety and enrollment update for Phase Ib/II trial

October 6, 2020

Immunicum has announced that a …

Sven Rohmann

Immunicum announces update on corporate and clinical development strategy

October 1, 2020

Immunicum has announced an update …

Sven Rohmann

He is the new Chief Executive Officer of Immunicum

August 28, 2020

Immunicum has announced that Sven …

Alex Karlsson Parra

Immunicum updates survival data from Phase II trial

August 18, 2020

Immunicum has announced an update …

Carlos de Sousa

Carlos de Sousa resigns as CEO of Immunicum

December 13, 2019

The Board of Directors of …

Immunicum announces positive preclinical data on Ilixadencel in combination with CTLA-4

October 23, 2019

The company has announced results …

Carlos de Sousa

Immunicum announces data analysis from Phase II trial

September 25, 2019

The company has announced the …

Carlos de Sousa

Exciting results from Immunicum

August 29, 2019

The company has announced positive …

1
2